Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Claire Dyke
Assessing the Tolerability and Efficacy of First-Line Chemotherapy in Elderly Patients With Metastatic HER2−ve Breast Cancer
ecancermedicalscience
Cancer Research
Oncology
Related publications
Use of Eribulin as an Earlier-Line Chemotherapy for Patients With HER2-negative Metastatic Breast Cancer
Journal of Cancer
Oncology
Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Capecitabine in Combination With Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: An Observational Study
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
A Phase II Study of Modified FOLFOX as First-Line Chemotherapy for Metastatic Gastric Cancer in Elderly Patients With Associated Diseases
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Nab-Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer With Visceral Crisis: Evaluation of Efficacy and Tolerability in Clinical Practice
Medical Council
Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Estimated Life-Years Saved in Women With HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
